Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men
- 2 August 2001
- journal article
- clinical trial
- Published by Springer Nature in International Journal of Obesity
- Vol. 25 (8) , 1136-1143
- https://doi.org/10.1038/sj.ijo.0801665
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart DiseaseJAMA, 1998
- Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levelsMetabolism, 1990
- Adiposity, Fat Distribution, and Cardiovascular RiskAnnals of Internal Medicine, 1989
- Biology of regional body fat distribution: Relationship to non‐insulin‐dependent diabetes mellitusDiabetes/Metabolism Research and Reviews, 1989
- Health Risks of ObesityMedical Clinics of North America, 1989
- Abdominal obesity and the development of noninsulin‐dependent diabetes mellitusDiabetes/Metabolism Research and Reviews, 1988
- Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesityMetabolism, 1987
- Relationship of Fat Distribution to Glucose Tolerance: Results of Computed Tomography in Male Participants of the Normative Aging StudyDiabetes, 1986
- Lowering Blood Cholesterol to Prevent Heart DiseaseJAMA, 1985
- Epidemiology of coronary heart disease: The Framingham studyThe American Journal of Medicine, 1984